Search

Your search keyword '"Respiratory syncytial virus -- Research"' showing total 16 results
Start Over Descriptor "Respiratory syncytial virus -- Research" Publisher university of chicago press
16 results on '"Respiratory syncytial virus -- Research"'

1. Distribution of airborne influenza virus and respiratory syncytial virus in an urgent care medical clinic

Author

Lindsley, William G., Blanchere, Francoise M., Davis, Kristine A., Pearce, Terri A., Fisher, Melanie A., Khakoo, Rashida, Davis, Stephen M., Rogers, Mark E., Thewlis, Robert E., Posada, Jose A., Redrow, John B., Celik, Ismail B., Chen, Bean T., and Beezhold, Donald H.

Subjects
Airborne infection -- Distribution, Airborne infection -- Research, Respiratory syncytial virus -- Distribution, Respiratory syncytial virus -- Research, Influenza viruses -- Distribution, Influenza viruses -- Research, Disease transmission -- Research, Company distribution practices, Health, Health care industry
Published
2010

3. Respiratory syncytial virus persistence in the lungs correlates with airway hyperreactivity in the mouse model

Author

Estripeaut, Dora, Torres, Juan Pablo, Somers, Cynthia S., Tagliabue, Claudia, Khokhar, Shama, Bhoj, Vijay G., Grube, Steve M., Wozniakowski, Aneta, Gomez, Ana M., Ramilo, Octavio, Jafri, Hasan S., and Mejias, Asuncion

Subjects
Respiratory syncytial virus -- Physiological aspects, Respiratory syncytial virus -- Research, Respiratory tract diseases -- Development and progression, Respiratory tract diseases -- Research, Animal models in research -- Usage, Animal models in research -- Physiological aspects, Animal models in research -- Research, Health
Published
2008

5. Human infant respiratory syncytial virus (RSV)-specific type 1 and 2 cytokine responses ex vivo during primary RSV infection

Author

Lee, F. Eun-Hyung, Walsh, Edward E., Falsey, Ann R., Lumb, Megan E., Okam, Ngozi V., Liu, Nathaniel, Divekar, Anagha A., Hall, Caroline B., and Mosmann, Tim R.

Subjects
Respiratory syncytial virus -- Physiological aspects, Respiratory syncytial virus -- Research, Respiratory syncytial virus infection -- Development and progression, Cytokines -- Research, Infants (Newborn) -- Diseases, Infants (Newborn) -- Research, Immune response -- Regulation, Immune response -- Research, Health
Published
2007

7. CD14 - 550 C/T, which is related to the serum level of soluble CD14, is associated with the development of respiratory syncytial virus bronchiolitis in the Japanese population

Author

Inoue, Yuzaburo, Shimojo, Naoki, Suzuki, Yoichi, Campos Alberto, Eduardo Jose, Yamaide, Akiko, Suzuki, Shuichi, Arima, Takayasu, Matsuura, Tomoko, Tomiita, Minako, Aoyagi, Masahiko, Hoshioka, Akira, Honda, Akihito, Hata, Akira, and Kohno, Yoichi

Subjects
Respiratory syncytial virus -- Development and progression, Respiratory syncytial virus -- Research, Chemokine receptors -- Genetic aspects, Genetic polymorphisms -- Research, T cells -- Genetic aspects, T cells -- Research, Japanese -- Health aspects, Health
Published
2007

8. Age-related differences in pulmonary cytokine response to respiratory syncytial virus infection: modulation by anti-inflammatory and antiviral treatment

Author

Boukhvalova, Marina S., Yim, Kevin C., Kuhn, Katie H., Hemming, John P., Prince, Gregory A., Porter, David D., and Blanco, Jorge C.G.

Subjects
Cytokines -- Research, Cytokines -- Physiological aspects, Respiratory tract diseases -- Causes of, Respiratory syncytial virus -- Research, Respiratory syncytial virus -- Health aspects, Antiviral agents -- Usage, Antiviral agents -- Research, Antiviral agents -- Health aspects, Immune response -- Regulation, Immune response -- Research, Health
Published
2007

9. The interferon antagonist NS2 protein of respiratory syncytial virus is an important virulence determinant for humans

Author

Wright, Peter F., Karron, Ruth A., Madhi, Shabir A., Treanor, John J., King, James C., O'Shea, Alice, Ikizler, Mine R., Zhu, Yuwei, Collins, Peter L., Cutland, Clare, Randolph, Valerie B., Deatly, Anne M., Hackell, Jill G., Gruber, William C., and Murphy, Brian R.

Subjects
Respiratory syncytial virus -- Research, Respiratory syncytial virus -- Diagnosis, Respiratory syncytial virus -- Complications and side effects, Severe acute respiratory syndrome -- Care and treatment, Severe acute respiratory syndrome -- Research, Severe acute respiratory syndrome -- Analysis, Health
Published
2006

11. Surveillance of clinical isolates of respiratory syncytial virus for palivizumab (synagis)-resistant mutants

Author

DeVincenzo, John P., Hall, Caroline B., Kimberlin, David W., Sanchez, Pablo J., Rodriguez, William J., Jantausch, Barbara A., Corey, Lawrence, Kahn, Jeffrey S., Englund, Janet A., Suzich, JoAnn A., Palmer-Hill, Frances J., Branco, Luis, Johnson, Syd, Patel, Nita K., and Piazza, Franco M.

Subjects
Drug resistance -- Research, Respiratory syncytial virus -- Research, Health, Synagis (Medication) -- Research
Published
2004

12. Association between common toll-like receptor 4 mutations and severe respiratory syncytial virus disease

Author

Tal, Guy, Mandelberg, Avigdor, Dalal, Ilan, Cesar, Karine, Somekh, Eli, Tal, Asher, Oron, Anat, Itskovich, Svetlana, Ballin, Ami, Houri, Sion, Beigelman, Avraham, Lider, Ofer, Rechavi, Gideon, and Amariglio, Ninette

Subjects
Bronchiolitis -- Care and treatment, Bronchiolitis -- Research, Infants -- Health aspects, Genetic polymorphisms -- Research, Respiratory syncytial virus -- Care and treatment, Respiratory syncytial virus -- Research, Health
Published
2004

13. Timing of infection and prior immunization with respiratory syncytial virus (RSV) in RSV-enhanced allergic inflammation

Author

Barends, M., van Oosten, M., de Rond, C.G.H., Dormans, J.A.M.A., Osterhaus, A.D.M.E., Neijens, H.J., and Kimman, T.G.

Subjects
Cytokines -- Health aspects, Paramyxoviruses -- Risk factors, Allergic reaction -- Care and treatment, Allergy -- Care and treatment, Respiratory syncytial virus -- Care and treatment, Respiratory syncytial virus -- Research, Health
Published
2004

14. Respiratory syncytial virus induces pneumonia, cytokine response, airway obstruction, and chronic inflammatory infiltrates associated with long-term airway hyperresponsiveness in mice

Author

Jafri, Hasan S., Chavez-Bueno, Susana, Mejias, Asuncion, Gomez, Ana M., Rios, Ana M., Nassi, Shahryar S., Yusuf, Munira, Kapur, Payal, Hardy, Robert D., Hatfield, Jeanine, Rogers, Beverly B., Krisher, Karen, and Ramilo, Octavio

Subjects
Cytokines -- Health aspects, Pneumonia -- Causes of, Pneumonia -- Research, Bacterial pneumonia -- Causes of, Bacterial pneumonia -- Research, Respiratory syncytial virus -- Risk factors, Respiratory syncytial virus -- Care and treatment, Respiratory syncytial virus -- Research, Health
Published
2004

16. Respiratory syncytial and parainfluenza viruses

Author

Heilman, Carole A.

Subjects
Influenza research -- Reports, Influenza viruses -- Prevention, Respiratory syncytial virus -- Research, Respiratory syncytial virus -- Prevention, Health
Abstract

The National Institute of Allergy and Infectious Diseases and the World Health Organization (WHO) sponsored a workshop in 1987 to assess the status of research projects concerning two viruses, the respiratory syncytial virus and the parainfluenza virus. The report focused on clinical aspects, genetic structure, protein function, treatment and vaccine development. The respiratory syncytial (RS) virus infects the breathing structures of infants and children. Epidemics of RS are responsible for costly hospital admissions due to bronchitis and pneumonia. The antibody response to RS, which normally protects the body against reinfection, is not well understood. The only treatment for RS is the antiviral drug ribavirin. The best response is seen when the drug is given early to high-risk children having life-threatening complications. Vaccine development is hampered by the young age at which many children contract RS and the high incidence of infection that can develop after vaccination. Researchers are investigating the use of recombinant virus vaccines and purified protein vaccines to introduce immunity. Antibodies that are made in the body naturally, immunoglobulins, are being assessed for their therapeutic use. Parainfluenza viruses are a group of viruses that cause bronchitis, pneumonia, croup and laryngitis in children. Early vaccines that used inactive viruses to elicit an immune response produced variable antibody production and no real protection was achieved. Purified protein vaccines administered through the nose, as well as live virus vaccines are currently being investigated. (Consumer Summary produced by Reliance Medical Information, Inc.)

Published
1990

Catalog

Books, media, physical & digital resources
See catalog results